Invest now
Acutaas Chemicals share price
High risk
You have to be logged in to add this to Watchlist.- ₹3,184.80(0.10%)September 8, 2026 15:27:11 PM IST
- NSE
- BSE
- Vol : 181.42 K (NSE + BSE)Last 20 day avg : 288.17 K
Acutaas Chemicals is trading 0.10% upper at Rs 3,184.80 as compared to its last closing price. Acutaas Chemicals has been trading in the price range of 3,237.85 & 3,170.50. Acutaas Chemicals has given 86.62% in this year & 0.66% in the last 5 days. Acutaas Chemicals has TTM P/E ratio 74.75 as compared to the sector P/E of 37.01.There are 6 analysts who have initiated coverage on Acutaas Chemicals. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 74.26 Crores in its last quarter.Listed peers of Acutaas Chemicals include Asian Paints (-0.76%), Solar Industries India (2.59%), Pidilite Industries (0.25%).The Mutual Fund holding in Acutaas Chemicals was at 14.17% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Acutaas Chemicals was at 21.61% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Sep 2026, 03:59 PM IST
- BetaLow volatility0.35Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.08Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.20The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Acutaas Chemicals News
Acutaas Chemicals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Asian Paints | 2,480.15 | -0.76 | 2,37,895.44 | 58.09 | 12.06 | 1.02 | 11.95 |
| Solar Industries India | 22,470.95 | 2.59 | 2,03,339.75 | 99.61 | 26.62 | 0.06 | 13.68 |
| Pidilite Industries | 1,589.00 | 0.25 | 1,61,741.08 | 64.76 | 14.71 | 0.73 | 2.03 |
| SRF | 2,527.85 | -0.36 | 74,931.75 | 44.57 | 6.07 | 0.31 | 14.26 |
| Linde India | 6,408.00 | 0.69 | 54,534.88 | 110.53 | 14.22 | 0.06 | 1.76 |
Mutual Fund Ownership
View allAcutaas Chemicals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
About the company Acutaas Chemicals
- IndustryChemical Manufacturing
- ISININE00FF01025
- BSE Code543349
- NSE CodeACUTAAS
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Acutaas Chemicals Share Price FAQs
Acutaas Chemicals is trading at 3184.80 as on Tue Sep 08 2026 09:57:11. This is 0.10% upper as compared to its previous closing price of 3181.55.
The market capitalization of Acutaas Chemicals is 26111.66 Cr as on Tue Sep 08 2026 09:57:11.
The average broker rating on Acutaas Chemicals is Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Acutaas Chemicals is 3735.00 whereas the 52 wk low is 1290.05
Acutaas Chemicals can be analyzed on the following key metrics -
- TTM P/E: 74.75
- Sector P/E: 37.01
- Dividend Yield: 0.08%
- D/E ratio: -
Acutaas Chemicals reported a net profit of 356.26 Cr in 2026.
The Mutual Fund Shareholding was 14.17% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Acutaas Chemicals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.